The IPO market is back from its annual month-long break, with the first listings since mid-August. The hot money has come with it. Despite a broad sell-off among China stocks, three Chinese companies priced US IPOs this week. All three priced at the low...read more
111, which operates an online retail drugstore and healthcare platform in China, raised $99 million by offering 7.1 million shares at $14, the low end of the range of $14 to $16. 111 plans to list on the NYSE under the symbol YI. J.P. Morgan, Citi and CICC...read more
Five IPOs are scheduled to raise $1.6 billion in the week ahead, the first batch since mid-August. As we highlighted in our Fall Preview, China is kick-starting Post-Labor Day deal flow:...read more
111, which runs an online retail drugstore and healthcare platform in China, announced terms for its IPO on Wednesday.
The Shanghai, China-based company plans to raise $140 million by offering 9.3 million ADSs at a price range of $14 to $16. Insiders intend...read more
US IPO Weekly Recap: IPO market returns from vacation with a 128% pop
The IPO market is back from its annual month-long break, with the first listings since mid-August. The hot money has come with it. Despite a broad sell-off among China stocks, three Chinese companies priced US IPOs this week. All three priced at the low...read more
111 prices downsized IPO at $14, the low end of the range
111, which operates an online retail drugstore and healthcare platform in China, raised $99 million by offering 7.1 million shares at $14, the low end of the range of $14 to $16. 111 plans to list on the NYSE under the symbol YI. J.P. Morgan, Citi and CICC...read more
US IPO Week Ahead: Fall IPO market starts up with 5 deals led by China's NIO
Five IPOs are scheduled to raise $1.6 billion in the week ahead, the first batch since mid-August. As we highlighted in our Fall Preview, China is kick-starting Post-Labor Day deal flow:...read more
Chinese online pharmacy 111 sets terms for $140 million US IPO
111, which runs an online retail drugstore and healthcare platform in China, announced terms for its IPO on Wednesday. The Shanghai, China-based company plans to raise $140 million by offering 9.3 million ADSs at a price range of $14 to $16. Insiders intend...read more